Overcoming Regulatory Challenges in Cognitive Drug Development

Methodological approaches for overcoming regulatory challenges through early FDA engagement

Read more

This paper describes some of the more salient regulatory challenges involved in determining the appropriateness and legitimacy of a possible target involving cognitive impairment associated with various CNS disorders and how to overcome these drug development challenges.


Chief Development Officer

Want to learn more about Worldwide Clinical Trials?